Compound dossier · evidence, sources, and live market
Cagrilintide
Amylin analog Moderate evidence 3 cited studies 51 live vendors
Cagrilintide is an amylin analog researched in laboratory settings for its potential role in metabolic and appetite-regulating pathways. This peptide is studied primarily for its effects on satiety signaling and energy balance in preclinical models.
Evidence brief
Cagrilintide is an investigational long-acting amylin analogue studied for weight management; the main standalone human data is a phase 2, dose-finding randomized trial.
first-party prices captured 37m ago
Compare by exact vialThe small sealed glass container a compound ships in. size: 5mg (26 vendors)10mg (40 vendors)
Investigational — not approved. As CagriSema (with semaglutide), Novo Nordisk filed an FDA application in Dec 2025; a decision is expected around late 2026.Research use only — not medical advice.
These figures are what pepmg still publishes about price: the floor, the middle, the spread and how many sources we track, computed from listings we captured first-party and refreshed on the same schedule as always. We no longer publish the individual listings or the sellers behind them.
Computed from 68 in-stock listings across 51 sources we captured first-party, with bulk vials, blends and statistical outliers excluded so the figures compare like with like. The spread is the highest tracked price divided by the lowest — how much the same milligram varies depending on where you look. The chart is the daily minimum; days we did not capture are left out rather than filled in.
- What the research says about cagrilintide Moderate evidence
Cagrilintide is an investigational long-acting amylin analogue studied for weight management; the main standalone human data is a phase 2, dose-finding randomized trial.
Read the full review → - Are research peptides safe? What the evidence does and doesn't show Limited evidence
"Are peptides safe?" has no single answer. The compounds sold as research peptides sit at very different points on the evidence scale, from large randomized human trials for a few to animal-only data for many.
Read the full review →
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial PubMed ↗
Natural amylin is a pancreatic hormone that induces satiety. Cagrilintide is a long-acting amylin analogue under investigation for weight management. We assessed the dose-response relationship of cagrilintide regarding the effects on…
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity PubMed ↗
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials; the efficacy of the combination (known as CagriSema) on weight…
- Development of Cagrilintide, a Long-Acting Amylin Analogue PubMed ↗
A hallmark of the pancreatic hormone amylin is its high propensity toward the formation of amyloid fibrils, which makes it a challenging drug design effort. The amylin analogue pramlintide is commercially available for diabetes treatment…
A few representative studies, each summarized on this site with the PubMed record linked beside it — not an endorsement or a claim that any result applies to human use. Read them and judge for yourself. Everything here is research use only.
▸ Why compare $/mg for Cagrilintide?
Per-mg prices for Cagrilintide vary significantly between vendors due to differences in synthesis scale, purity verification, and batch consistency. Comparing prices helps researchers identify cost-effective sources while ensuring the compound meets their research-grade specifications.
▸ Reading the COA
For Cagrilintide, a Certificate of Analysis should confirm identity via mass spectrometry and purity by HPLC, typically above 98%. Check for common adulterants like residual solvents or truncated peptide fragments, and verify that the stated mass matches the actual fill weight to avoid under-filling.
▸ FAQ
▸ Same cluster
| Retatrutide | $2.02/mg | vs Cagrilintide → |
| Tirzepatide | $1.35/mg | vs Cagrilintide → |
| Semaglutide | $1.22/mg | vs Cagrilintide → |
| AOD-9604 | $4.00/mg | vs Cagrilintide → |
| HGH Frag 176-191 | $5.73/mg | vs Cagrilintide → |
| 5-Amino-1MQ | $0.80/mg | vs Cagrilintide → |
| Survodutide | $7.39/mg | vs Cagrilintide → |
| Mazdutide | $5.72/mg | vs Cagrilintide → |
| Teduglutide | $2.37/mg | |
| Orforglipron | $21.50/mg | vs Cagrilintide → |
| Tesofensine | $159.98/mg | vs Cagrilintide → |
| SLU-PP-332 | $3.33/mg | vs Cagrilintide → |
| BAM15 | $1.96/mg | vs Cagrilintide → |
| AICAR | $0.63/mg | vs Cagrilintide → |
| Adipotide | $7.60/mg | vs Cagrilintide → |
| L-Carnitine | $9.90/mg |